Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $164B | +$2.68B | 258 | 4.61% | Increased |
|
| 2 |
BlackRock
New York
| $154B | +$4.3B | 277 | 4.93% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $90.6B | -$473M | 267 | 5.43% | Reduced |
|
| 4 |
JP Morgan Chase
New York
| $34B | +$3B | 225 | 4.74% | Increased |
|
| 5 |
Geode Capital Management
Boston,
Massachusetts
| $33.5B | +$1.02B | 296 | 4.91% | Increased |
|
| 6 |
Wellington Management Group
Boston,
Massachusetts
| $33.3B | -$2.61B | 76 | 6.71% | Reduced |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $32.5B | +$2.93B | 212 | 3.23% | Increased |
|
| 8 |
Morgan Stanley
New York
| $29.3B | +$8.02B | 304 | 3.8% | Increased |
|
| 9 |
T. Rowe Price Associates
Baltimore,
Maryland
| $25.7B | -$1.2B | 128 | 3.25% | Reduced |
|
| 10 |
Capital International Investors
Los Angeles,
California
| $25.4B | +$3.61B | 21 | 6.9% | Increased |
|
| 11 |
Capital World Investors
Los Angeles,
California
| $25B | +$2.42B | 24 | 5.32% | Increased |
|
| 12 |
Bank of America
Charlotte,
North Carolina
| $24.8B | +$2.33B | 256 | 2.82% | Increased |
|
| 13 |
Northern Trust
Chicago,
Illinois
| $22.9B | -$81.7M | 248 | 4.89% | Reduced |
|
| 14 |
Bank of New York Mellon
New York
| $20.4B | +$362M | 189 | 4.66% | Increased |
|
| 15 |
Norges Bank
Oslo,
Norway
| $17.4B | -$291M | 59 | 4.49% | Reduced |
|
| 16 |
Charles Schwab
San Francisco,
California
| $15.4B | +$74.7M | 157 | 5.35% | Increased |
|
| 17 |
Legal & General Group
London,
United Kingdom
| $13.8B | +$261M | 149 | 4.88% | Increased |
|
| 18 |
BBA
Baker Bros. Advisors
New York
| $13.7B | +$6.6M | 48 | 77.71% | Increased |
|
| 19 |
Primecap Management
Pasadena,
California
| $12.6B | -$49.3M | 19 | 11.28% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $12.4B | +$1.71B | 218 | 3.09% | Increased |
|
| 21 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $12B | +$18.9M | 138 | 6.67% | Increased |
|
| 22 |
Ameriprise
Minneapolis,
Minnesota
| $11.9B | -$364M | 79 | 4.17% | Reduced |
|
| 23 |
Capital Research Global Investors
Los Angeles,
California
| $11.9B | +$380M | 11 | 3.7% | Increased |
|
| 24 |
Dodge & Cox
San Francisco,
California
| $11.8B | -$1.48B | 12 | 8.15% | Reduced |
|
| 25 |
Wells Fargo
San Francisco,
California
| $11.7B | -$693M | 277 | 3.61% | Reduced |
|